Cough Syrup Ban: Health Authorities Act After Child Deaths
Health authorities have issued a warning against prescribing cough syrup to children under two years old. This follows investigations into child deaths in Madhya Pradesh and Rajasthan, which revealed potential hazards in certain cough syrups.
The Ministry of Health confirmed these findings and initiated risk-based inspections across the country. In Tamil Nadu, authorities have taken stringent measures. They have banned the sale of Coldrif Cough Syrup and halted its production. The manufacturer, Sresan Pharmaceuticals, has been identified as the source of the contaminated product. The company's main plant is located in Kancheepuram, Tamil Nadu, with a unit in Sunguvarchathram. Tests have shown that Coldrif Cough Syrup from the Kanchipuram unit contained diethylene glycol (DEG) above permissible limits.
The ban on Coldrif Cough Syrup and the halt in its production aim to prevent further harm. Health authorities urge caution in prescribing cough syrups to young children. Further investigations are ongoing to ensure the safety of other products and prevent similar incidents in the future.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Trump Signs Law Defunding Planned Parenthood, Threatening Healthcare Access for Millions
- Historian Ute Frevert Explores Germans' Emotional Bond With Constitutions
- Milei's Ideological Approach Reshapes Argentina's Foreign Policy
